Chemomab Therapeutics Ltd.

CMMB · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
142
SEC Filings
$2.02
Close 2026-05-22
12
Employees

Business Summary

Overview Chemomab is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet needs. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory di...

Latest Stock Quote

CMMB 2026-05-22 $2.02 O:$1.83 H:$2.0859 L:$1.83 Vol:0.1M VWAP:$1.9901
origin leaf: 26f11276176b10bff99c314cee4a204e7459116045f1d3914925763d0afbd380

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2023-03-202022-12-310001178913-23-001041EDGAR80K words
2022-03-302021-12-310001178913-22-001304EDGAR—
2021-03-092020-12-310001104659-21-033822EDGAR—
2020-03-172019-12-310001104659-20-034835EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2023-05-112023-03-310001178913-23-001807EDGAR10K words
2022-11-102022-09-300001178913-22-003931EDGAR—
2022-08-122022-06-300001178913-22-003074EDGAR—
2022-05-122022-03-310001178913-22-001919EDGAR—
2021-11-122021-09-300001178913-21-003509EDGAR—
2021-08-132021-06-300001178913-21-002696EDGAR—
2021-05-132021-03-310001104659-21-065588EDGAR—
2020-11-162020-09-300001104659-20-125523EDGAR—
2020-08-142020-06-300001104659-20-095149EDGAR—
2020-05-072020-03-310001104659-20-058143EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2023-06-160001178913-23-002225EDGAR1K words
2023-06-050001178913-23-002136EDGAR—
2023-05-110001178913-23-001809EDGAR—
2023-02-210001178913-23-000679EDGAR—
2023-02-210001178913-23-000670EDGAR—
2023-01-110001178913-23-000147EDGAR—
2023-01-030001178913-23-000010EDGAR—
2022-11-160001178913-22-004061EDGAR—
2022-11-140001178913-22-004019EDGAR—
2022-08-120001178913-22-003072EDGAR—

142 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001534248
TickerCMMB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedL3
Websitehttps://www.chemomab.com
Listed2021-03-17

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7c8104fc252ca91617ed009e22103f79b4e4a566bb2b12d368b92d241875ca53
parent: d0b42ebd664c564db0c03c63d3fe373d0beb2ce33ffecde18eb4522f112eb99b
content hash: a570b9db6e2f46c1edd15cd77113fb142ba7f7a1cac429c16b8f160524d0ec99
signed: 2026-06-02T19:00:41.778Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf